Taysha Gene Therapies, Inc. - TSHA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | President and Head of R&D | S | D | 200,000.0 | 6.24 | 1,248,000.0 | 936,410.0 | View | |
| Jun 02, 2026 | — | A | A | 42,671.0 | 0.0 | 0.0 | 42,671.0 | View | |
| Jun 02, 2026 | — | A | A | 21,335.0 | 0.0 | 0.0 | 1,176,559.0 | View | |
| Jun 02, 2026 | — | A | A | 42,671.0 | 0.0 | 0.0 | 42,671.0 | View | |
| Jun 02, 2026 | — | A | A | 21,335.0 | 0.0 | 0.0 | 241,289.0 | View | |
| Jun 02, 2026 | — | A | A | 42,671.0 | 0.0 | 0.0 | 42,671.0 | View | |
| Jun 02, 2026 | — | A | A | 21,335.0 | 0.0 | 0.0 | 127,178.0 | View | |
| Jun 02, 2026 | — | A | A | 42,671.0 | 0.0 | 0.0 | 42,671.0 | View | |
| Jun 02, 2026 | — | A | A | 21,335.0 | 0.0 | 0.0 | 127,178.0 | View | |
| Apr 13, 2026 | President and Head of R&D | M | D | 19,021.0 | 0.0 | 0.0 | 455,920.0 | View | |
| Apr 13, 2026 | President and Head of R&D | S | D | 200,000.0 | 4.46 | 892,000.0 | 1,136,410.0 | View | |
| Apr 13, 2026 | President and Head of R&D | M | A | 19,021.0 | 1.71 | 32,525.91 | 1,336,410.0 | View |